TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Polar Biomedicals AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
18,719
|
17,983
|
16,190 |
| Financial expenses |
191
|
310
|
196 |
| Earnings before taxes |
3,044
|
1,419
|
873 |
| Total assets |
10,809
|
9,037
|
8,675 |
| Current assets |
10,771
|
9,019
|
8,672 |
| Current liabilities |
3,938
|
3,783
|
3,303 |
| Equity capital |
6,871
|
5,255
|
5,372 |
| - share capital |
258
|
272
|
290 |
| Employees (average) | 2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
63.6%
|
58.1%
|
61.9% |
| Turnover per employee | 8,095 | ||
| Profit as a percentage of turnover |
16.3%
|
7.9%
|
5.4% |
| Return on assets (ROA) |
29.9%
|
19.1%
|
12.3% |
| Current ratio |
273.5%
|
238.4%
|
262.5% |
| Return on equity (ROE) |
44.3%
|
27.0%
|
16.3% |
| Change turnover |
1,638
|
2,789
|
-1,455 |
| Change turnover % |
10%
|
18%
|
-8% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.